Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents
Christoph P. Hornik(Duke University), Daniel González(University of North Carolina at Chapel Hill), David Speicher(Rainbow Babies & Children's Hospital), Peter M. Mourani(Arkansas Children's Hospital), Michael Cohen‐Wolkowiez(Duke University), Michelle Adu‐Darko(University of Virginia Children's Hospital), Barrie Harper(Clinical Research Institute), Kevin Watt(University of Utah), Chiara Melloni, Amira Al‐Uzri(Oregon Health & Science University), Susan Lin(Emmes (United States)), Andrew M. Atz(Medical University of South Carolina), Casey E. Gelber(Emmes (United States)), Janice E. Sullivan(University of Louisville), Elizabeth H. Payne(Emmes (United States)), Ram Yogev(Northwestern University)
Cited by 12
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828